49. 全身性エリテマトーデス [臨床試験数:827,薬物数:638(DrugBank:168),標的遺伝子数:108,標的パスウェイ数:191

Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
5 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01953835October 4, 201326/9/2013A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184A Two-part Healthy Volunteer Study to Investigate Both the Interaction of GSK2586184 With Rosuvastatin and Simvastatin and to Compare the Pharmacokinetics of Two Different Formulations of GSK2586184Systemic Lupus ErythematosusDrug: GSK2586184 standard formulation;Drug: Simvastatin;Drug: Rosuvastatin;Drug: GSK2586184 new formulationGlaxoSmithKlineNULLCompleted18 Years65 YearsAll37Phase 1United States
2NCT01170585July 201026/7/2010A Trial of Rosuvastatin in Systemic Lupus ErythematosusA Randomised Placebo Controlled Trial of Rosuvastatin in Systemic Lupus ErythematosusAtherosclerosis;Systemic Lupus ErythematosusDrug: Rosuvastatin;Drug: PlaceboImperial College LondonNULLCompleted18 Years80 YearsBoth33Phase 2United Kingdom
3EUCTR2006-006214-16-GB23/02/201029/02/2008A randomised placebo controlled trial of rosuvastatin in systemic lupus erythematosus. - RCT of statin in SLEA randomised placebo controlled trial of rosuvastatin in systemic lupus erythematosus. - RCT of statin in SLE Systemic lupus erythematosus.
MedDRA version: 13.1 Level: LLT Classification code 10042944 Term: Systemic lupus erythematosis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
Imperial CollegeNULLNot Recruiting Female: yes
Male: yes
64 Human pharmacology (Phase 1): no Therapeut1c exploratory (Phase 2): no Therapeut1c conf1rmatory - (Phase 3): no Therapeut1c use (Phase 4): yesUnited Kingdom
4NCT00866229April 200819/3/2009Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol LevelEfficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in SLE Patients With Corticosteroid Therapy and High LDL Cholesterol LevelSystemic Lupus Erythematosus;High LDL Cholesterol LevelDrug: Rosuvastatin;Drug: SimvastatinRamathibodi HospitalAstraZenecaRecruiting18 Years60 YearsBoth140Phase 4Thailand
5NCT00371501June 20061/9/2006Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus ErythematosusLow Dose Aspirin and Statins for Primary Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus: A Randomized Double-blind Placebo-controlled TrialAtherosclerosis;Thromboembolism;Systemic Lupus ErythematosusDrug: Rosuvastatin;Drug: placebo;Drug: aspirinTuen Mun HospitalAstraZenecaCompleted18 YearsN/ABoth72Phase 4Hong Kong